-
Role
-
EVP & Chief Legal Officer
-
Signature
-
/s/ Priscilla Duncan-Tannous, Attorney-in-Fact
-
Stock symbol
-
LEVI
-
Transactions as of
-
May 31, 2023
-
Transactions value $
-
-$79,234
-
Form type
-
4
-
Date filed
-
6/1/2023, 08:04 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
LEVI |
Class A Common Stock |
+Conversion of derivative security |
$0 |
+2,938 |
+1.69% |
$0.00 |
176,670 |
May 31, 2023 |
Direct |
F1, F2 |
transaction |
LEVI |
Class A Common Stock |
-Sell |
-$39,516 |
-2,938 |
-1.66% |
$13.45 |
173,732 |
May 31, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
LEVI |
Stock Appreciation Rights |
-Options Exercise |
$0 |
-12,055 |
-11.11% |
$0.00 |
96,435 |
May 31, 2023 |
Class B Common Stock |
12,055 |
$6.90 |
Direct |
F1, F3, F4 |
transaction |
LEVI |
Class B Common Stock |
+Options Exercise |
$83,180 |
+12,055 |
+5.28% |
$6.90 |
240,535 |
May 31, 2023 |
Class A Common Stock |
12,055 |
|
Direct |
F1, F4 |
transaction |
LEVI |
Class B Common Stock |
-Disposed to Issuer |
-$122,897 |
-9,117 |
-3.79% |
$13.48 |
231,418 |
May 31, 2023 |
Class A Common Stock |
9,117 |
|
Direct |
F1, F4, F5 |
transaction |
LEVI |
Class B Common Stock |
-Conversion of derivative security |
$0 |
-2,938 |
-1.27% |
$0.00 |
228,480 |
May 31, 2023 |
Class A Common Stock |
2,938 |
|
Direct |
F1, F2, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: